Larvol Delta - BioPath-Holdings-Announces-First-Patient-Dosed-in-Phase-11b-Study-of-BP1002-in-RefractoryRelapsed-Acute-Myeloid-Leukemia-Patients

liposomal Bcl2 (BP1002) - Bio-Path

https://www.globenewswire.com/news-release/2022/10/24/2539808/0/en/Bio-Path-Holdings-Announces-First-Patient-Dosed-in-Phase-1-1b-Study-of-BP1002-in-Refractory-Relapsed-Acute-Myeloid-Leukemia-Patients.html

Oct 24, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next